MNOV logo

Medicinova, Inc.


MNOV: MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.


Show MNOV Financials

Consumer Interest
SEC Filings

Recent trades of MNOV by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by MNOV's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases


Number of mentions of MNOV in WallStreetBets Daily Discussion


Recent insights relating to MNOV

CNBC Recommendations

Recent picks made for MNOV stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MNOV

Corporate Flights

Flights by private jets registered to MNOV